TickerFactsScreenerDevelopers

Immix Biopharma, Inc. (IMMX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$453.9K2021: -$1.35M2022: -$8.22M2023: -$16.14M2024: -$22.67M2025: -$29.96M-$29.96M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$29.96M-32.1%
2024-$22.67M-40.5%
2023-$16.14M-96.4%
2022-$8.22M-507.9%
2021-$1.35M-197.9%
2020-$453.9K—